[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Baker, SG, Joffe, BI, Mendelsohn, D. & Seftel, 1982 - Google Patents

Treatment of homozygous familial hypercholesterolaemia with probucol

Baker, SG, Joffe, BI, Mendelsohn, D. & Seftel, 1982

View PDF
Document ID
2398959904381899965
Author
Baker, SG, Joffe, BI, Mendelsohn, D. & Seftel H
Publication year
Publication venue
South African Medical Journal

External Links

Snippet

Treatment of homozygous familial hypercholesterolaemia with probucol Page 1 SA MEDICAL JOURNAL VOLUME 62 3 JULY 1982 7 Treatment of homozygous familial hypercholesterolaemia with probucol SG BAKER, Summary B. I. JOFFE, D.MENDELSOHN, HCSEFTEL far as we …
Continue reading at journals.co.za (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Baker, SG, Joffe, BI, Mendelsohn, D. & Seftel Treatment of homozygous familial hypercholesterolaemia with probucol
Schwartz et al. Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives
Chamberlain et al. Plasma digoxin concentrations in patients with atrial fibrillation
Dymock et al. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis
Bowen et al. Diurnal variation in glucose tolerance
Reynolds et al. Restless leg syndrome and rheumatoid arthritis.
Skarfors et al. Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men. A feasibility study over 2 years
Nathan et al. Non-insulin-dependent diabetes in older patients: complications and risk factors
Kanis et al. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
Jaques et al. Intrapulmonary heparin: A new procedure for anticoagulant therapy
Sumner et al. Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.
Lindström et al. Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure
Bourey et al. Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds
KINNEY et al. The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers
Bertorini et al. Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy
Mallis et al. Superior bioavailability of digoxin solution in capsules
Cathcart et al. Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.
Golding et al. Observations on the treatment of rheumatoid disease with penicillamine
Ritschel Bioavailability in the clinical evaluation of drugs
Anderson et al. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: Clinical application of a new assay for bretylium
Gilbert et al. Acute hemodynamic response to low dose enoximone (MDL 17,043): An oral dose-range study
Meyer et al. Renal function in the elderly
Aronson et al. Digoxin therapy: Textbooks, theory and practice
Bertler et al. Massive digoxin intoxication: Report of two cases with pharmacokinetic correlations
Gey et al. Quinidine plasma concentration and exertional arrhythmia